48,830
edits
Difference between revisions of "Neuromuscular pathology"
Jump to navigation
Jump to search
Neuromuscular pathology (view source)
Revision as of 03:39, 27 October 2010
, 03:39, 27 October 2010→Approach: ref, central
(more) |
(→Approach: ref, central) |
||
| Line 108: | Line 108: | ||
#Size variation - in groups (neurogenic) vs. singular (myogenic). | #Size variation - in groups (neurogenic) vs. singular (myogenic). | ||
#Shape - angulated (neurogenic) vs. round (myogenic). | #Shape - angulated (neurogenic) vs. round (myogenic). | ||
#Position of nuclei. | #Position of nuclei - peripheral (normal); central (myogenic; centronuclear myopathy<ref>URL: [http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html]. Accessed on: 26 October 2010.</ref>). | ||
#Necrosis - suggests myogenic. | #Necrosis - suggests myogenic. | ||
#Fibrosis - suggests myogenic. | #Fibrosis - suggests myogenic. | ||
#Inflammation. | #Inflammation - suggest myogenic vs. systemic inflammatory. | ||
Other: | Other: | ||
#Obvious abnormality vs. minimal change. | #Obvious abnormality vs. minimal change. | ||